Reduction in liver transplant wait ‐listing in the era of direct‐acting antiviral therapy
Conclusion: The rate of LT WL for HCV complicated by DC has decreased by over 30% in the era of DAA therapy. Further reductions in WL are anticipated with increased testing, linkage to care, and access to DAA therapy. (Hepatology 2016).
Source: Hepatology - Category: Internal Medicine Authors: Jennifer A. Flemming, W. Ray Kim, Carol L. Brosgart, Norah A. Terrault Tags: Viral Hepatitis Source Type: research
More News: Antiviral Therapy | Cancer & Oncology | Carcinoma | Cirrhosis | Databases & Libraries | Hepatitis | Hepatitis B | Hepatitis C | Hepatocellular Carcinoma | Internal Medicine | Liver | Liver Cancer | Liver Disease | Liver Transplant | Study | Transplant Surgery | Transplants | Urology & Nephrology